All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

236

Reset

236 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • [18F]-APN-1607Phase 32 trials

    JYAMS PET Research & Development Limited · Alzheimer's Disease, Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementia

  • 4-MUSTtrimebutine 4-methylumbelliferyl sulfatePhase 32 trials

    Valenta Pharm JSC · Chronic Cholecystitis, Biliary Dyskinesia

  • AMX0035Phase 32 trials

    Amylyx Pharmaceuticals Inc. · Wolfram Syndrome, Progressive Supranuclear Palsy, PSP

  • BHV-2000Taldefgrobep, BMS-986089Phase 32 trials

    Biohaven Pharmaceuticals, Inc. · Spinal Muscular Atrophy, Neuromuscular Diseases, SMA

  • BR005-036CPhase 32 trials

    Brise Pharmaceuticals Co., Ltd. · Migraine, With or Without Aura

  • ScandiBio Therapeutics AB · Alzheimer Disease, Gout Disease

  • CVN424Phase 32 trials

    Cerevance · Parkinson Disease, Parkinson's Disease

  • DeramiocelCAP-1002, Allogeneic Cardiosphere-Derived CellsPhase 32 trials

    Capricor Inc. · Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic

  • DMB-IINN: Latrepirdine, DimebonPhase 32 trials

    Bigespas LTD · Alzheimer Type Dementia, Alzheimer Disease, Dementia of Alzheimer Type

  • DSPPhase 32 trials

    Dompé Farmaceutici S.p.A · Atopic Keratoconjunctivitis, Ataxia Telangiectasia

  • GM1Phase 32 trials

    Qilu Pharmaceutical Co., Ltd. · Chemotherapy-induced Peripheral Neuropathy (CIPN), Parkinson's Disease

  • KYV-101Phase 32 trials

    Kyverna Therapeutics · Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis

  • matched to PregabalinPhase 32 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain

  • matched to SUZPhase 32 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain

  • Sanofi · Multiple Sclerosis

  • NomlabofuspCTI-1601Phase 32 trials

    Larimar Therapeutics, Inc. · Friedreich Ataxia, Friedreich's Ataxia

  • NRTX-1001GABA-secreting interneuronsPhase 32 trials

    Neurona Therapeutics · Epilepsy, Temporal Lobe, Mesial Temporal Lobe Epilepsy

  • NucresiranALN-TTRSC04Phase 32 trials

    Alnylam Pharmaceuticals · Transthyretin Amyloidosis With Cardiomyopathy, Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy, hATTR-PN

  • ONO-2808Phase 32 trials

    Ono Pharmaceutical Co., Ltd. · Multiple System Atrophy, Parkinson Variant, Multiple System Atrophy (MSA)

  • PBOPhase 32 trials

    SK Life Science, Inc. · Primary Generalized Epilepsy, Treatment Resistant Depression

  • PridopidinePhase 32 trials

    Prilenia · Amyotrophic Lateral Sclerosis, Huntington Disease

  • SemagludtidePhase 32 trials

    Lumos Pharma · Obesity & Overweight, Early Alzheimer's Disease

  • SGT-003Phase 32 trials

    Solid Biosciences Inc. · Duchenne Muscular Dystrophy, Advanced Solid Tumor

  • Staccato alprazolamUCB7538Phase 32 trials

    UCB · Stereotypical Prolonged Seizures

  • TAK-771Phase 32 trials

    Takeda · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Multifocal Motor Neuropathy (MMN), Primary Immunodeficiency Diseases (PID)

  • Shanghai Zhimeng Biopharma, Inc. · ALS (Amyotrophic Lateral Sclerosis), Focal Epilepsy

  • YJ001Phase 32 trials

    Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. · Diabetic Peripheral Neuropathic Pain (DPNP)

  • Zeleciment RostudirsenDYNE-251Phase 32 trials

    Dyne Therapeutics · Duchenne Muscular Dystrophy (DMD), Muscular Dystrophy, Duchenne, Muscular Dystrophy (DMD)

  • ABP 692Phase 31 trial

    Amgen · Relapsing-remitting Multiple Sclerosis (RRMS)

  • AR1001Phase 31 trial

    AriBio Co., Ltd. · Alzheimer Disease

  • AXS-07meloxicam-rizatriptanPhase 31 trial

    Axsome Therapeutics, Inc. · Migraine

  • BCD-281Phase 31 trial

    Biocad · Relapsing-remitting Multiple Sclerosis (RRMS)

  • bemdaneprocelMSK-DA01, BRT-DA01Phase 31 trial

    BlueRock Therapeutics · Parkinsons Disease (PD)

  • BHV-8000Phase 31 trial

    Biohaven Therapeutics Ltd. · Parkinson Disease

  • COYA 302Phase 31 trial

    Coya Therapeutics · Amyotrophic Lateral Sclerosis (ALS)

  • elsunersenPhase 31 trial

    Praxis Precision Medicines · Epileptic Encephalopathy, SCN2A Encephalopathy

  • EXV-801deramciclanePhase 31 trial

    Exciva GmbH · Agitation Associated With Alzheimer's Disease Dementia

  • EXV-802Phase 31 trial

    Exciva GmbH · Agitation Associated With Alzheimer's Disease Dementia

  • HSK16149Phase 31 trial

    Haisco Pharmaceutical Group Co., Ltd. · Central Neuropathic Pain

  • Wanbangde Pharmaceutical Group Co., LTD · Alzheimer Dementia

  • ION363Phase 31 trial

    Ionis Pharmaceuticals · Amyotrophic Lateral Sclerosis

  • JZP926Phase 31 trial

    Jazz Pharmaceuticals · Juvenile Myoclonic Epilepsy

  • MLC 901Phase 31 trial

    Moleac Pte Ltd. · Alzheimer's Disease Dementia

  • MN-166ibudilastPhase 31 trial

    MediciNova · Amyotrophic Lateral Sclerosis

  • RemternetugLY3372993Phase 31 trial

    Eli Lilly · Alzheimer's Disease

  • SUVN-502MasupirdinePhase 31 trial

    Suven Life Sciences Limited · Agitation, Alzheimer's Type Dementia

  • VG081821ACVG081821Phase 31 trial

    Zhejiang Vimgreen Pharmaceuticals, Ltd. · Parkinson Disease (PD)

  • XTR006[18F]MK 6240, FlorquinitauPhase 31 trial

    Sinotau Pharmaceutical Group · Alzheimer Disease, Neurofibrillary Tangle

  • rapcabtagene autoleucelYTB323Phase 28 trials

    Novartis · Lupus Nephritis, Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD), ANCA Associated Vasculitis (AAV)

  • UC-MSCRY_SW01 cell, Human umbilical cord mesenchymal stem cellsPhase 28 trials

    Jiangsu Renocell Biotech Company · Acute Respiratory Distress Syndrome, Lupus Nephritis, Spinocerebellar Ataxia Type 1

NewerPage 2 of 5Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.